| Literature DB >> 19386672 |
Lucy Selman1, Irene J Higginson, Godfrey Agupio, Natalya Dinat, Julia Downing, Liz Gwyther, Thandi Mashao, Keletso Mmoledi, Anthony P Moll, Lydia Mpanga Sebuyira, Barbara Panajatovic, Richard Harding.
Abstract
OBJECTIVES: To explore the information needs of patients with progressive, life limiting disease and their family caregivers in South Africa and Uganda and to inform clinical practice and policy in this emerging field.Entities:
Mesh:
Year: 2009 PMID: 19386672 PMCID: PMC3273778 DOI: 10.1136/bmj.b1326
Source DB: PubMed Journal: BMJ ISSN: 0959-8138
Description of services and number of participants recruited, by site
| Site | Area served | Service type | Source of most of funding | No of patients cared for (2007-8) | Type of patients cared for | Patients recruited (n=90) | Family carers recruited (n=38) | Total (n=128) |
|---|---|---|---|---|---|---|---|---|
| A | Urban | Homecare, day care, outpatient clinic, hospital consultancy, and outreach to healthcare clinics through three branches | Local, national, and international donors | 2396 | Patients with advanced cancer or advanced HIV | 20 | 10 | 30 |
| B | Urban township | Four sister hospices, all offering short term (2-3 week) inpatient care; two also offer home care | Local, national, international donors | 1607 | Patients with HIV, cancer, or other progressive incurable conditions | 20 | 3 | 23 |
| C | Urban township | Homecare, outpatient clinic, and inpatient unit attached to hospital | Government and international donors | 1818 | Patients with cancer, HIV, or MND, from diagnosis until point of death | 12 | 3 | 15 |
| D | Rural | Homecare and inpatient unit close to hospital | Global Fund for AIDS, Tuberculosis and Malaria | 847 | Patients with HIV, from diagnosis until point of death | 18 | 12 | 30 |
| E | Rural, peri-urban, and urban township | Homecare, day care, and inpatient unit | Local, national, and international donors, including Global Fund for AIDS, Tuberculosis and Malaria | 1290 | Patients with cancer, HIV, or MND, from diagnosis until point of death | 20 | 10 | 30 |
MND=motor neurone disease.
Characteristics of sample across sites. Values are numbers (percentage) unless stated otherwise
| Demographic characteristic | Patients (n=90) | Carers (n=38) |
|---|---|---|
| Mean (SD; range) age (years) | 43.2 (15.4; 18-84) | 44.8 (17.5; 19-77)* |
| Female | 58 (64) | 32 (84)* |
| Responsible for children? | ||
| Yes | 68 (76) | 30 (79)* |
| Mean (SD; range) No of children | 2.8 (1.8; 1-9) | 3.1 (1.6; 1-8) |
| Mean (SD; range) household size | 5.2 (5.0; 1-20)† | 7.1 (3.5; 2-20)* |
| Location of home: | ||
| Urban | 23 (26) | 4 (11) |
| Peri-urban | 26 (29) | 10 (26) |
| Rural | 41 (46) | 24 (63) |
| Primary diagnosis: | ||
| Motor neurone disease | 1 (1) | NA |
| Cancer only | 28 (31) | |
| HIV | 61 (68) | |
| Of HIV positive patients: | ||
| On antiretroviral therapy | 39 (64) | NA |
| Previous AIDS diagnosis | 54 (89) | |
| Dual HIV-cancer diagnosis | 6 (10) | |
| ECOG functional status: | ||
| Fully active | 10 (11) | NA |
| Restricted | 24 (27) | |
| Ambulatory | 17 (19) | |
| Limited self care | 25 (28) | |
| Completely disabled | 14 (16) | |
| Primary place of palliative care: | ||
| Home | 56 (62) | NA |
| Inpatient unit | 27 (30) | |
| Outpatient clinic | 3 (3) | |
| Day care | 4 (4) | |
| Weeks under palliative care | ||
| Mean (SD) | 51.4 (85.2)† | NA |
| Median (range) | 15.0 (0-427) |
ECOG=Eastern Cooperative Oncology Group; NA=not applicable.
*Three missing.
†One missing.
Breakdown of characteristics of sample by site. Values are numbers (percentages) unless stated otherwise
| Demographic characteristic | Site A | Site B | Site C | Site D | Site E | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Patients (n=20) | Carers (n=10) | Patients (n=20) | Carers (n=3) | Patients (n=12) | Carers (n=3) | Patients (n=18) | Carers (n=12) | Patients (n=20) | Carers (n=10) | |
| Mean (SD; range) age (years) | 43.1 (12.5; 21-70) | 41.8 (18.6; 19-77) | 46.3 (17.4; 19-75) | 45.3 (23.3; 29-72) | 35.0 (7.6; 21-49) | 40.3 (15.0; 26-56) | 35.4 (9.9; 20-57) | 33.6 (8.2; 25-46)* | 52.0 (18.4; 18-84) | 59.2 (14.5; 35-74) |
| Female | 15 (75) | 8 (80) | 11 (55) | 3 (100) | 10 (83) | 2 (67) | 10 (56) | 9 (75)* | 12 (60) | 10 (100) |
| Responsible for children? | ||||||||||
| Yes | 18 (90) | 9 (90) | 18 (90) | 3 (100) | 9 (75) | 2 (67) | 15 (83) | 9 (75.0)* | 8 (40) | 7 (70) |
| Mean (SD; range) No of children | 3.6 (2.0; 1-9) | 3.7 (2.2; 1-8) | 2.7 (1.8; 1-7) | 1.3 (0.6; 1-2) | 1.7 (2.0; 1-2) | 2 (0; 2) | 2.5 (1.8; 1-8) | 3.1 (0.8;2-4)* | 3.3 (1.5;1-6) | 3.3 (1.6; 1-6) |
| Mean (SD; range) household size | 6.9 (4.1; 2-20) | 8.7 (5.3; 2-20) | 4.32 (4.0; 1-10)† | 6 (2.6; 4-9) | 4.8 (1.7; 2-8) | 6 (2.0; 4-8) | 6.3 (2.20; 4-13) | 7.9 (7.0; 6-14)* | 3.7 (2.2; 1-9) | 5.3 (2.0; 2-9) |
| Location of home: | ||||||||||
| Urban | 0 | 0 | 0 | 0 | 12 (100) | 3 (100) | 0 | 0 | 11 (55) | 1 (10) |
| Peri-urban | 11 (55) | 7 (70) | 14 (70) | 2 (67) | 0 | 0 | 0 | 0 | 1 (5) | 1 (10) |
| Rural | 9 (45) | 3 (30) | 6 (30) | 1 (33) | 0 | 0 | 18 (100) | 12 (100) | 8 (40) | 8 (80) |
| Primary diagnosis: | ||||||||||
| MND | 0 | NA | 1 (5) | NA | 0 | NA | 0 | NA | 0 | NA |
| Cancer only | 6 (30) | 8 (40) | 2 (17) | 0 | 12 (60) | |||||
| HIV | 14 (70) | 11 (55) | 10 (83) | 18 (100) | 8 (40) | |||||
| Of HIV positive patients: | ||||||||||
| On antiretroviral therapy | 8 (57) | NA | 8 (73) | NA | 7 (70) | NA | 15 (83) | NA | 1 (13) | NA |
| Previous AIDS diagnosis | 11 (79) | 11 (100) | 10 (100) | 17 (94) | 5 (63) | |||||
| Dual HIV-cancer diagnosis | 3 (21) | 0 | 1 (10) | 1 (6) | 1 (13) | |||||
| ECOG functional status: | ||||||||||
| Fully active | 1 (5) | NA | 0 | NA | 1 (8) | NA | 2 (11) | NA | 6 (30) | NA |
| Restricted | 10 (50) | 0 | 4 (33) | 0 | 10 (50) | |||||
| Ambulatory | 0 | 12 (60) | 3 (25) | 0 | 2 (10) | |||||
| Limited self care | 5 (25) | 6 (30) | 2 (17) | 12 (67) | 0 | |||||
| Completely disabled | 4 (20) | 2 (10) | 2 (17) | 4 (22) | 2 (10) | |||||
| Primary place of palliative care: | ||||||||||
| Home | 16 (80) | NA | 5 (25) | NA | 12 (100) | NA | 7 (39) | NA | 16 (80) | NA |
| Inpatient unit | 1 (5) | 14 (70) | 0 | 11 (61) | 1 (5) | |||||
| Outpatient clinic | 3 (15) | 0 | 0 | 0 | 0 | |||||
| Day care | 0 | 1 (5) | 0 | 0 | 3 (15) | |||||
| Weeks under palliative care: | ||||||||||
| Mean (SD) | 60.7 (69.8)† | NA | 19.3 (35.4) | NA | 47.0 (43.3) | NA | 4.0 (7.3) | NA | 120.2 (135.4) | NA |
| Median (range) | 29.0 (3-264)† | 2.0 (1-140) | 29.0 (3-104) | 0.50 (0-28) | 46.5 (3-427) | |||||
ART=antiretroviral therapy; ECOG=Eastern Cooperative Oncology Group; MND=motor neurone disease; NA=not applicable.
*Three missing.
†One missing.
Barriers to information provision and recommended solutions
| Barriers identified | Recommended solutions |
|---|---|
| Tailor communication to needs and abilities of individual patients and caregivers; check patient’s understanding after key discussions | |
| Continuous assessment of information needs throughout disease trajectory; culturally sensitive, proactive provision of information | |
| Education and training for generalists in palliative care communication skills, including breaking bad news and family conferences; record key discussions in patient notes; access to counsellors for referral of patients where necessary; advice and support from palliative care trained staff throughout disease trajectory |